Related Experiment Videos
Dying-back oligodendrogliopathy: a late sequel of myelin-associated glycoprotein deficiency
H Lassmann1, U Bartsch, D Montag
1Institute of Neurology, University of Vienna, Austria.
Abstract:
Ultrastructural analysis of myelin from 8-month-old mice deficient in the myelin-associated glycoprotein revealed pronounced and characteristic alterations of the periaxonal oligodendrocyte processes, consisting of intracytoplasmic deposition of vesicular material, multivesicular bodies, mitochondria, and lipofuscin granules, as well as granular or paracrystalline inclusions. These alterations are similar to those described before as "dying-back oligodendrogliopathy" in diseases of toxic or immune-mediated demyelination including multiple sclerosis.
Insights
Mice lacking myelin-associated glycoprotein showed abnormal oligodendrocyte processes, resembling "dying-back oligodendrogliopathy" seen in demyelinating diseases like multiple sclerosis.
Area of Science:
- Neuroscience
- Cell Biology
- Demyelinating Diseases
Background:
- Myelin-associated glycoprotein (MAG) plays a role in myelin maintenance.
- Oligodendrocytes are glial cells responsible for myelinating axons in the central nervous system.
- Dying-back oligodendrogliopathy is a pathological process observed in various demyelinating conditions.
Purpose of the Study:
- To investigate the ultrastructural consequences of myelin-associated glycoprotein deficiency in oligodendrocytes.
- To compare the observed alterations with known patterns of dying-back oligodendrogliopathy.
Main Methods:
- Ultrastructural analysis using electron microscopy.
- Examination of periaxonal oligodendrocyte processes in 8-month-old mice genetically deficient in MAG.
Main Results:
- Mice deficient in MAG exhibited significant alterations in periaxonal oligodendrocyte processes.
- These alterations included intracytoplasmic deposition of vesicular material, multivesicular bodies, mitochondria, and lipofuscin granules.
- Granular or paracrystalline inclusions were also observed within the oligodendrocyte processes.
Conclusions:
- MAG deficiency leads to characteristic ultrastructural changes in oligodendrocytes.
- These changes mirror the pathology of dying-back oligodendrogliopathy.
- This suggests a potential role for MAG in oligodendrocyte health and myelin integrity, relevant to diseases like multiple sclerosis.